Subxiphoid uniportal VATS
leijiang2
Phase 3 other active
Quick answer
Subxiphoid uniportal VATS for Mediastinal Neoplasms is a Phase 3 program (other) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- China SXT Pharmaceuticals
- Indication
- Mediastinal Neoplasms
- Phase
- Phase 3
- Modality
- other
- Status
- active